Isabelle Schilling

Ms. Isabelle Schilling

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2022 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
CBC Behrends
C Behrends
CBC M Bäcker
C M Bäcker
ISIsabelle Schilling
Isabelle Schilling
SZS Zwiehoff
S Zwiehoff
JWJens Weingarten
Jens Weingarten
BTB Timmermann
B Timmermann
Objective. Due to the radiosensitizing effect of biocompatible noble metal nanoparticles (NPs), their administration is considered to potentially increase tumor control in radiotherapy. The underlying physical, chemical and biological mechanisms of the NPs’ radiosensitivity especially when interacting with proton radiation is not conclusive. In the following work, the energy deposition of protons in matter containing platinum nanoparticles (PtNPs) is experimentally investigated. Approach. Surfactant-free monomodal PtNPs with a mean diameter of (40 ± 10) nm and a concentration of 300 μg ml −1 , demonstrably leading to a substantial production of reactive oxygen species (ROS), were homogeneously dispersed into cubic gelatin samples serving as tissue-like phantoms. Gelatin samples without PtNPs were used as control. The samples’ dimensions and contrast of the PtNPs were verified in a clinical computed tomography scanner. Fields from a clinical proton machine were used for depth dose and stopping power measurements downstream of both samples types. These experiments were performed with a variety of detectors at a pencil beam scanning beam line as well as a passive beam line with proton energies from about 56–200 MeV. Main results. The samples’ water equivalent ratios in terms of proton stopping as well as the mean proton energy deposition downstream of the samples with ROS-producing PtNPs compared to the samples without PtNPs showed no differences within the experimental uncertainties of about 2%. Significance. This study serves as experimental proof that the radiosensitizing effect of biocompatible PtNPs is not due to a macroscopically increased proton energy deposition, but is more likely caused by a catalytic effect of the PtNPs. Thus, these experiments provide a contribution to the highly discussed radiobiological question of the proton therapy efficiency with noble metal NPs and facilitate initial evidence that the dose calculation in treatment planning is straightforward and not affected by the presence of sensitizing PtNPs.

1 November 2022 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
ISIsabelle Schilling
Isabelle Schilling
CBClaus Maximillian Bäcker
Claus Maximillian Bäcker
CBChristian Bäumer
Christian Bäumer
CBCarina Behrends
Carina Behrends
KKKevin Kröninger
Kevin Kröninger
JWJens Weingarten
Jens Weingarten
The advanced imaging and delivery techniques in proton therapy allow conformal high-dose irradiation of the target volume with high accuracy using pencil beam scanning or beam shaping apertures. These irradiation methods increasingly include small radiation fields with large dose gradients, which require detector systems with high spatial resolution for quality assurance. In addition the measurement of all success parameters for daily quality assurance with only one proton field and one simple detector system would save a lot of time in clinical usage. Based on their good spatial resolution and high rate compatibility, pixelated silicon detectors could meet the new requirements. To assess their applicability in proton therapy, ATLAS pixelated silicon detectors are used to measure the lateral beam profile with high spatial resolution. Furthermore, a dose dependent detector calibration is presented to allow the measurement of the requested output constancy. A strategy to verify the proton energy during the daily quality assurance is under study. Promising results from proof-of-principle measurements at the West German Proton Therapy Centre in Essen, Germany, have been obtained.

29 November 2022 in Instruments
Verified
Journal Article
Open access
PDF file
ISIsabelle Schilling
Isabelle Schilling
CBClaus Maximilian Baecker
Claus Maximilian Baecker
CBChristian Bäumer
Christian Bäumer
CBCarina Behrends
Carina Behrends
MHMarius Hötting
Marius Hötting
JWJens Weingarten
Jens Weingarten
The accurate measurement of the beam range in the frame of quality assurance (QA) is a requirement for clinical use of a proton therapy machine. Conventionally used detectors mostly estimate the range by measuring the depth dose distribution of the protons. In this paper, we use pixel detectors designed for individual particle tracking in the high-radiation environment of the ATLAS experiment at LHC. The detector measures the deposited energy in the sensor for individual protons. Due to the limited dynamic energy range of the readout chip, several ways to measure the proton energy or range are examined. A staircase phantom is placed on the detector to perform an energy calibration relative to the NIST PSTAR stopping power database. In addition, track length measurements are performed using the detector aligned parallel with the beam axis to investigate the Linear Energy Transfer (LET) per pixel along the trajectory of individual protons. In this proof-of-principle study, we show that this radiation hardness detector can successfully be used to determine the initial proton energy for protons impinging on the sensor with an energy below 44 MeV after the range shifters. It becomes clear that an improvement of the energy resolution of the readout chip is required for clinical use.